Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.25 $4.30 Thursday, 9th May 2024 GERN stock ended at $3.88. This is 1.84% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 3.16% from a day low at $3.80 to a day high of $3.92.
90 days $1.64 $4.30
52 weeks $1.64 $4.30

Historical Geron Corporation prices

Date Open High Low Close Volume
Aug 10, 2016 $2.73 $2.74 $2.65 $2.65 966 700
Aug 09, 2016 $2.72 $2.74 $2.66 $2.73 743 600
Aug 08, 2016 $2.78 $2.80 $2.70 $2.72 1 345 100
Aug 05, 2016 $2.73 $2.78 $2.72 $2.76 1 324 400
Aug 04, 2016 $2.73 $2.76 $2.66 $2.71 1 701 300
Aug 03, 2016 $2.71 $2.78 $2.68 $2.78 1 469 400
Aug 02, 2016 $2.71 $2.76 $2.66 $2.72 1 469 400
Aug 01, 2016 $2.68 $2.75 $2.66 $2.71 1 095 000
Jul 29, 2016 $2.66 $2.70 $2.64 $2.68 802 700
Jul 28, 2016 $2.75 $2.78 $2.66 $2.66 1 065 800
Jul 27, 2016 $2.66 $2.75 $2.66 $2.75 1 474 300
Jul 26, 2016 $2.63 $2.69 $2.62 $2.64 983 200
Jul 25, 2016 $2.63 $2.68 $2.60 $2.64 675 400
Jul 22, 2016 $2.70 $2.71 $2.64 $2.66 861 500
Jul 21, 2016 $2.67 $2.73 $2.65 $2.70 1 631 900
Jul 20, 2016 $2.58 $2.66 $2.58 $2.66 987 700
Jul 19, 2016 $2.59 $2.66 $2.57 $2.57 1 333 600
Jul 18, 2016 $2.65 $2.69 $2.64 $2.66 1 022 200
Jul 15, 2016 $2.63 $2.66 $2.58 $2.66 737 600
Jul 14, 2016 $2.66 $2.69 $2.60 $2.62 1 058 100
Jul 13, 2016 $2.77 $2.77 $2.63 $2.64 1 431 700
Jul 12, 2016 $2.77 $2.78 $2.69 $2.70 1 466 300
Jul 11, 2016 $2.73 $2.79 $2.71 $2.75 1 417 300
Jul 08, 2016 $2.70 $2.75 $2.68 $2.72 1 478 700
Jul 07, 2016 $2.68 $2.74 $2.63 $2.69 1 060 300
Click to get the best stock tips daily for free!

About Geron Corporation

Geron Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes a... GERN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT